Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice

J A Albrecht1, Y Dong, J Wang

  • 1Department of Surgery, Emory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.

Insights

BK polyomavirus infection timing and viral load significantly impact kidney allograft injury, with recipient infection causing severe damage. The study suggests PVAN involves immune responses, not just viral cytopathology.

Area of Science:

  • Nephrology
  • Virology
  • Immunology

Background:

  • BK polyomavirus-associated nephropathy (PVAN) is a major cause of kidney transplant failure.
  • Understanding PVAN pathogenesis is limited by the species specificity of polyomaviruses.

Purpose of the Study:

  • To investigate clinically relevant factors influencing polyomavirus-associated allograft nephropathy (PVAN) using a mouse model.
  • To elucidate the mechanisms underlying PVAN development in kidney allografts.

Main Methods:

  • Utilized a mouse polyomavirus (MPyV) kidney transplant model.
  • Varied timing and source of MPyV infection, viral inoculum titer, MHC matching, and ischemia/reperfusion injury.
  • Employed splenectomized alymphoplasia mice to assess the role of adaptive immunity.

Main Results:

  • Acute recipient infection with high-titer MPyV resulted in the most severe PVAN.
  • MHC matching and prolonged cold ischemia did not significantly alter PVAN severity.
  • Persistent high viral loads alone were insufficient to cause advanced PVAN in immunodeficient mice.
  • Survival correlated with serum creatinine, not kidney allograft viral loads.

Conclusions:

  • PVAN severity is influenced by MPyV infection dynamics (timing, source, titer) in the recipient.
  • The mechanism of PVAN involves an interplay between viral infection and the recipient's immune response against the donor.
  • Viral cytopathology alone does not drive advanced PVAN; immune-mediated mechanisms are critical.